BACKGROUND: Successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) can markedly reduce angina symptom burden, but many patients often remain on multiple antianginal medications (AAMs) after the procedure. It is unclear when, or if, AAMs can be de-escalated to prevent adverse effects or limit polypharmacy. We examined the association of de-escalation of AAMs after CTO PCI with long-term health status. METHODS: In a 12-center registry of consecutive CTO PCI patients, health status was assessed at 6 months after successful CTO PCI with the Seattle Angina Questionnaire and the Rose Dyspnea Scale. Among patients with technical CTO PCI success, we examined the association of AAM de-escalation with 6-month health status using multivariable models adjusting for revascularization completeness and predicted risk of post-PCI angina (using a validated risk model). We also examined predictors and variability of AAMs de-escalation. RESULTS: Of 669 patients with technical success of CTO PCI, AAMs were de-escalated in 276 (35.9%) patients at 1 month. Patients with AAM de-escalation reported similar angina and dyspnea rates at 6 months compared with those whose AAMs were reduced (any angina: 22.5% vs 20%, P = .43; any dyspnea: 51.8% vs 50.1%, P = .40). In a multivariable model adjusting for complete revascularization and predicted risk of post-PCI angina, de-escalation of AAMs at 1 month was not associated with an increased risk of angina, dyspnea, or worse health status at 6 months. CONCLUSIONS: Among patients with successful CTO PCI, de-escalation of AAMs occurred in about one-third of patients at 1 month and was not associated with worse long-term health status.
BACKGROUND: Successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) can markedly reduce angina symptom burden, but many patients often remain on multiple antianginal medications (AAMs) after the procedure. It is unclear when, or if, AAMs can be de-escalated to prevent adverse effects or limit polypharmacy. We examined the association of de-escalation of AAMs after CTO PCI with long-term health status. METHODS: In a 12-center registry of consecutive CTO PCI patients, health status was assessed at 6 months after successful CTO PCI with the Seattle Angina Questionnaire and the Rose Dyspnea Scale. Among patients with technical CTO PCI success, we examined the association of AAM de-escalation with 6-month health status using multivariable models adjusting for revascularization completeness and predicted risk of post-PCI angina (using a validated risk model). We also examined predictors and variability of AAMs de-escalation. RESULTS: Of 669 patients with technical success of CTO PCI, AAMs were de-escalated in 276 (35.9%) patients at 1 month. Patients with AAM de-escalation reported similar angina and dyspnea rates at 6 months compared with those whose AAMs were reduced (any angina: 22.5% vs 20%, P = .43; any dyspnea: 51.8% vs 50.1%, P = .40). In a multivariable model adjusting for complete revascularization and predicted risk of post-PCI angina, de-escalation of AAMs at 1 month was not associated with an increased risk of angina, dyspnea, or worse health status at 6 months. CONCLUSIONS: Among patients with successful CTO PCI, de-escalation of AAMs occurred in about one-third of patients at 1 month and was not associated with worse long-term health status.
Authors: John A Spertus; David J Maron; David J Cohen; Paul Kolm; Pam Hartigan; William S Weintraub; Daniel S Berman; Koon K Teo; Leslee J Shaw; Steven P Sedlis; Merril Knudtson; Mihaela Aslan; Marcin Dada; William E Boden; G B John Mancini Journal: Circ Cardiovasc Qual Outcomes Date: 2013-07-09
Authors: David M Safley; J Aaron Grantham; Jason Hatch; Philip G Jones; John A Spertus Journal: Catheter Cardiovasc Interv Date: 2013-12-19 Impact factor: 2.692
Authors: Suzanne V Arnold; Mikhail Kosiborod; Yan Li; Philip G Jones; Patrick Yue; Luiz Belardinelli; John A Spertus Journal: Circ Cardiovasc Qual Outcomes Date: 2014-09-23
Authors: Suzanne V Arnold; Frederick A Masoudi; John S Rumsfeld; Yan Li; Philip G Jones; John A Spertus Journal: Circulation Date: 2013-10-25 Impact factor: 29.690
Authors: Karen P Alexander; Giora Weisz; Kristi Prather; Stefan James; Daniel B Mark; Kevin J Anstrom; Linda Davidson-Ray; Adam Witkowski; Angel J Mulkay; Anna Osmukhina; Ramin Farzaneh-Far; Ori Ben-Yehuda; Gregg W Stone; E Magnus Ohman Journal: Circulation Date: 2015-11-10 Impact factor: 29.690
Authors: Suzanne V Arnold; David A Morrow; Yang Lei; David J Cohen; Elizabeth M Mahoney; Eugene Braunwald; Paul S Chan Journal: Circ Cardiovasc Qual Outcomes Date: 2009-06-02
Authors: Anthony J Barron; Nabeela Zaman; Graham D Cole; Roland Wensel; Darlington O Okonko; Darrel P Francis Journal: Int J Cardiol Date: 2013-06-21 Impact factor: 4.164
Authors: Mohammed Qintar; Arooge Towheed; Fengming Tang; Adam C Salisbury; P Michael Ho; J Aaron Grantham; John A Spertus; Suzanne V Arnold Journal: J Am Heart Assoc Date: 2017-10-20 Impact factor: 5.501